Global Information
회사소개 | 문의 | 위시리스트

변비 : 파이프라인 리뷰

Constipation - Pipeline Review, H1 2019

리서치사 Global Markets Direct
발행일 2019년 02월 상품 코드 192536
페이지 정보 영문 100 Pages
가격
US $ 2,000 ₩ 2,308,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,616,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,000 ₩ 6,924,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


변비 : 파이프라인 리뷰 Constipation - Pipeline Review, H1 2019
발행일 : 2019년 02월 페이지 정보 : 영문 100 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

변비는 대변을 보기 어렵거나 빈도가 적은 경우에 일어납니다. 변비 증상에는 복부 팽창 또는 복통, 통증 및 구토 등이 있습니다. 소인에는 섭식 장애, 과민성장증후군, 갑상선 기능 저하증, 변비약 과다 사용, 과로, 장근육의 쇠약, 스트레스, 수분 섭취 부족, 식사시 섬유 부족 등이 포함됩니다. 치료에는 변비약 사용과 적절한 라이프스타일을 들 수 있습니다.

세계의 변비(Constipation) 치료제 파이프라인에 대해 조사했으며, 현재 개발 파이프라인 상황과 최신 동향, 치료제 개요, 주요 기업 및 개발중인 제품 리뷰 등의 정보를 전해드립니다.

목차

서론

  • 분석 범위

변비 개요

치료제 개발

  • 변비용 파이프라인 제품 : 개요
  • 변비용 파이프라인 제품 : 비교 분석

변비 : 개발중인 치료제 - 기업별

변비 : 개발중인 치료제 - 대학/연구기관별

변비 : 파이프라인 제품 개요

  • 후기 단계 제품
  • 임상 단계 제품
  • 초기 단계 제품

변비 : 개발중인 제품 - 기업별

변비 : 개발중인 제품 - 대학/연구기관별

변비 : 치료제 개발에 참여하고 있는 기업

  • AlbireoPharma
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Braintree Laboratories, Inc.
  • CJ HealthCare Corp.
  • Daiichi-Sankyo
  • Ironwood Pharmaceuticals, Inc.
  • Kissei Pharmaceutical Co., Ltd.
  • NGM Biopharmaceuticals, Inc.
  • RaQualia Pharma Inc.
  • Rhythm Pharmaceuticals, Inc.
  • Sanwa Kagaku Kenkyusho Co., Ltd.
  • Shire Plc
  • SK Biopharmaceuticals Co., Ltd.
  • Sucampo Pharmaceuticals, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Synergy Pharmaceuticals, Inc.
  • Synthetic Biologics, Inc.
  • Yuhan Corporation

변비 : 치료제 평가

  • 단독치료 제품(Monotherapy Products)별
  • 표적별
  • 작용기전별
  • 투여경로별
  • 분자종류별

치료제 개요

  • ASP-7663
    • 제품 개요
    • 작용기전
    • R&D 진전 상황
  • BLI-400
  • DA-6886
  • DS-3801
  • DSP-6952
  • elobixibat
  • KWA-0711
  • linaclotide
  • lubiprostone
  • NGM-282
  • plecanatide
  • prucalopride succinate
  • relamorelin
  • relenopride hydrochloride
  • RQ-00000010
  • SK-1202
  • Small Molecule to Activate 5-HT1 Receptor for Constipation and Dyspepsia
  • Small Molecule to Inhibit IBAT for Chronic Constipation and Irritable Bowel Syndrome
  • SYN-010
  • tenapanor hydrochloride
  • Transilon
  • YH-12852

최신 파이프라인 동향

휴지 상태인 프로젝트

제품 개발 마일스톤

  • 주목 뉴스 및 프레스 릴리스

부록

도표

LSH 16.04.04

List of Tables

  • Number of Products under Development for Constipation, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Products under Development by Companies, H1 2019
  • Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Stage and Target, H1 2019
  • Number of Products by Stage and Mechanism of Action, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Constipation - Pipeline by Allergan Plc, H1 2019
  • Constipation - Pipeline by Ardelyx Inc, H1 2019
  • Constipation - Pipeline by Braintree Laboratories Inc, H1 2019
  • Constipation - Pipeline by Dong-A ST Co Ltd, H1 2019
  • Constipation - Pipeline by Ironwood Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Kissei Pharmaceutical Co Ltd, H1 2019
  • Constipation - Pipeline by MallInckrodt Plc, H1 2019
  • Constipation - Pipeline by NGM Biopharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by RaQualia Pharma Inc, H1 2019
  • Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, H1 2019
  • Constipation - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2019
  • Constipation - Pipeline by Synergy Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Synthetic Biologics Inc, H1 2019
  • Constipation - Pipeline by Vanda Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Yuhan Corp, H1 2019
  • Constipation - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H1 2019
  • Constipation - Dormant Projects, H1 2019
  • Constipation - Discontinued Products, H1 2019

List of Figures

  • Number of Products under Development for Constipation, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products by Top 10 Targets, H1 2019
  • Number of Products by Stage and Top 10 Targets, H1 2019
  • Number of Products by Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Routes of Administration, H1 2019
  • Number of Products by Stage and Routes of Administration, H1 2019
  • Number of Products by Molecule Types, H1 2019
  • Number of Products by Stage and Molecule Types, H1 2019

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Constipation - Pipeline Review, H1 2019, provides an overview of the Constipation (Gastrointestinal) pipeline landscape.

Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. Treatment includes use of laxatives and proper lifestyle.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Constipation - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 8, 2, 4, 1 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Constipation (Gastrointestinal).
  • The pipeline guide reviews pipeline therapeutics for Constipation (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Constipation (Gastrointestinal) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Constipation (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Constipation (Gastrointestinal)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Constipation (Gastrointestinal).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Constipation (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Introduction
  • Constipation - Overview
  • Constipation - Therapeutics Development
  • Constipation - Therapeutics Assessment
  • Constipation - Companies Involved in Therapeutics Development
  • Constipation - Drug Profiles
  • Constipation - Dormant Projects
  • Constipation - Discontinued Products
  • Constipation - Product Development Milestones
  • Appendix
Back to Top
전화 문의
F A Q
 
BCC Research